By Silke Koltrowitz and Manas Mishra (Reuters) – Nestle pays $2 billion to purchase the remaining stake in Aimmune Therapeutics Inc , gaining full possession of the primary U.S.-approved peanut…
By Silke Koltrowitz and Manas Mishra (Reuters) – Nestle pays $2 billion to purchase the remaining stake in Aimmune Therapeutics Inc , gaining full possession of the primary U.S.-approved peanut…